News 14/01/2021 RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies RheinCell Therapeutics offers fully characterized clinical-grade iPSCs for cell therapy development and commercialization
Cell and Gene Therapy 08/01/2021 Creating a Next Generation CDMO An interview with Jerrod Denham, VP of Manufacturing at Ology Bioservices
Cell and Gene Therapy 06/01/2021 Testing strategies and custom assay development for cell and cell-based therapies An interview with Ward Carter, Chief Operating Officer, QualTex Laboratories
Member Zone 17/12/2020 6 Ways to Nail Your Commercialisation Strategy A collection of the outcomes from the roundtables and panels that took place at Advanced Therapies Connect 2020
Cell and Gene Therapy 09/12/2020 22 Investment Funds for Advanced Therapies Understanding the investment landscape for advanced therapy biotech and technology enablers
Advanced Therapies 24/11/2020 Diversity & Inclusion in Advanced Therapies In this eBook we highlight eight cell and gene therapy companies that are making positive change through diversity and...
Cell and Gene Therapy 24/11/2020 AAV vector manufacturing: Transfection matters Optimising the transfection process and its efficiency is paramount to boosting vector titres during scale-up and manufacturing...
Cell and Gene Therapy 02/11/2020 Advanced Therapies Manufacturing Capacity in North America A comprehensive guide showcasing the growing cell and gene therapy and viral vector manufacturing landscape in North...
Cell and Gene Therapy 13/10/2020 Exploring Dedicated Donor Paradigms as a Solution to Advanced... By Dominic Clarke, Global Head of Cell Therapy at HemaCare
Cell and Gene Therapy 12/10/2020 Improving the Flexibility and Predictability of CAR-T Manufacturing Getting CAR-T product pipelines to market faster: saving time, money and improving flexibility and predictability
Cell and Gene Therapy 28/09/2020 Technology Review: In-process Analytics for Advanced Therapies Edition Three of Phacilitate’s technology review series examines in-process analytics tools that will innovate and improve commercial-scale cell...
Phacilitate Talks 18/09/2020 Episode 6 David Smith, Akron Biotech and Oliver Ball, Stemmatters Dave and Oli share their views on what's slowing down cell therapy approval rates
Cell and Gene Therapy 15/09/2020 [WEBINAR] Point of Care Manufacturing for Next-Generation Advanced... On-demand access to a live webinar from 22nd October 2020
Cell and Gene Therapy 02/09/2020 Enabling Patient Access to Personalised Cell Therapies Through... Dr Ohad Karnieli talks to us about point-of-care manufacturing challenges, solid tumour treatments and taking inspiration from... McDonald's
Phacilitate Talks 02/09/2020 Episode 5 Women in Advanced Therapies Special with Maria Fardis,... Maria Fardis and Nicola Ambler talk about TILs, mentorship and the importance of partnering
